Tiziana Life Sciences Ltd (NASDAQ:TLSA) shareholders (or potential shareholders) will be happy to see that the CEO & Executive Director, Ivor Elrifi, recently bought a whopping US$667k worth of stock, at a price of US$1.00. Aside from being a solid chunk in its own right, the deft move also saw their holding increase by some 18%.

Tiziana Life Sciences Insider Transactions Over The Last Year

Notably, that recent purchase by Ivor Elrifi is the biggest insider purchase of Tiziana Life Sciences shares that we've seen in the last year. So it's clear an insider wanted to buy, even at a higher price than the current share price (being US$0.97). While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. To us, it's very important to consider the price insiders pay for shares. Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. The only individual insider to buy over the last year was Ivor Elrifi.

Ivor Elrifi bought 988.42k shares over the last 12 months at an average price of US$1.00. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.

Insider Ownership Of Tiziana Life Sciences

Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. Tiziana Life Sciences insiders own about US$62m worth of shares (which is 48% of the company). This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

So What Do The Tiziana Life Sciences Insider Transactions Indicate?

The recent insider purchase is heartening. We also take confidence from the longer term picture of insider transactions. But we don't feel the same about the fact the company is making losses. When combined with notable insider ownership, these factors suggest Tiziana Life Sciences insiders are well aligned, and quite possibly think the share price is too low. Looks promising! So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing.

But note: Tiziana Life Sciences may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.